AMPK-dependent hormonal regulation of whole-body energy metabolism

被引:70
作者
Dzamko, N. L.
Steinberg, G. R. [1 ]
机构
[1] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
基金
英国医学研究理事会;
关键词
adipokines; fatty acid metabolism; gluconeogenesis; insulin sensitivity; obesity; skeletal muscle; ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ACETYL-COA CARBOXYLASE; HUMAN SKELETAL-MUSCLE; NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; GLUCOSE-UPTAKE; MALONYL-COA; MESSENGER-RNA; FOOD-INTAKE;
D O I
10.1111/j.1748-1716.2009.01969.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
AMP-dependent protein kinase (AMPK) is an evolutionarily conserved serine/threonine protein kinase central to the regulation of energy balance at both the cellular and whole-body levels. In its classical role as an intracellular metabolic stress-sensing kinase, AMPK switches on fatty acid oxidation and glucose uptake in muscle, while switching off hepatic gluconeogenesis. AMPK also has a broader role in metabolism through the control of appetite. Regulation of AMPK activity at the whole-body level is coordinated by a growing number of hormones and cytokines secreted from adipose tissue, skeletal muscle, pancreas and the gut including leptin, adiponectin, insulin, interluekin-6, resistin, TNF-alpha and ghrelin. Understanding how these secreted signalling proteins regulate AMPK activity to control fatty acid oxidation, glucose uptake, gluconeogenesis and appetite may yield therapeutic treatments for metabolic disorders such as diabetes, insulin resistance and obesity.
引用
收藏
页码:115 / 127
页数:13
相关论文
共 144 条
[1]   The subcellular localization of acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Brinkley, WR ;
Zhong, L ;
Chirala, SS ;
Woldegiorgis, G ;
Wakil, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1444-1449
[2]   Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Matzuk, MM ;
Abo-Hashema, KAH ;
Wakil, SJ .
SCIENCE, 2001, 291 (5513) :2613-2616
[3]   HUMAN ACETYL-COA CARBOXYLASE - CHARACTERIZATION, MOLECULAR-CLONING, AND EVIDENCE FOR 2 ISOFORMS [J].
ABUELHEIGA, L ;
JAYAKUMAR, A ;
BALDINI, A ;
CHIRALA, SS ;
WAKIL, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :4011-4015
[4]   Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle [J].
Al-Khalili, Lubna ;
Bouzakri, Karim ;
Glund, Stephan ;
Lonnqvist, Fredrik ;
Koistinen, Heikki A. ;
Krook, Anna .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (12) :3364-3375
[5]   Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle [J].
Alam, N ;
Saggerson, ED .
BIOCHEMICAL JOURNAL, 1998, 334 :233-241
[6]   Hypothalamic CaMKK2 contributes to the regulation of energy balance [J].
Anderson, Kristin A. ;
Ribar, Thomas J. ;
Lin, Fumin ;
Noeldner, Pamela K. ;
Green, Michelle F. ;
Muehlbauer, Michael J. ;
Witters, Lee A. ;
Kemp, Bruce E. ;
Means, Anthony R. .
CELL METABOLISM, 2008, 7 (05) :377-388
[7]   AMP-activated protein kinase plays a role in the control of food intake [J].
Andersson, U ;
Filipsson, K ;
Abbott, CR ;
Woods, A ;
Smith, K ;
Bloom, SR ;
Carling, D ;
Small, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12005-12008
[8]   Liver adenosine monophosphate-activated kinase-α2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin [J].
Andreelli, F ;
Foretz, M ;
Knauf, C ;
Cani, PD ;
Perrin, C ;
Iglesias, MA ;
Pillot, B ;
Bado, A ;
Tronche, F ;
Mithieux, G ;
Vaulont, S ;
Burcelin, R ;
Viollet, B .
ENDOCRINOLOGY, 2006, 147 (05) :2432-2441
[9]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[10]   Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects [J].
Bandyopadhyay, Gautam K. ;
Yu, Joseph G. ;
Ofrecio, Jachelle ;
Olefsky, Jerrold M. .
DIABETES, 2006, 55 (08) :2277-2285